Adult ADHD Trial Win; Suicide Drug Ditched; Mental Health Toll in War Zones

Derick Alison
Derick Alison
2 Min Read

The narcolepsy drug solriamfetol (Sunosi) significantly improved attention deficit-hyperactivity disorder (ADHD) symptoms in a small randomized trial. (Journal of Clinical Psychiatry)

Marking World Mental Health Day this week, a U.S. News & World Report survey found that nearly 93% of people agreed that mental health care is just as important as physical health care.

Novartis threw in the towel on a phase II trial testing the novel NMDA receptor antagonist MIJ821 for major depressive disorder with suicidal ideation. (Fierce Biotech)

The investigational add-on drug evenamide significantly improved symptoms in patients with treatment-resistant schizophrenia in a 6-month phase II trial, Newron Pharmaceuticals announced.

Can running be as effective as antidepressants? (Everyday Health)

There was a larger spike in use of lysergic acid diethylamide — better known as the hallucinogen LSD — among young adults with depression than the general population between 2008 and 2019. (JAMA Psychiatry)

Strategies targeting certain adversities such as parental separation during adolescence among those with parents with mental illness could improve outcomes later in life. (JAMA Network Open)

California Gov. Gavin Newsom (D) signed a new law reforming the conservatorship system, in a move to overhaul the state’s mental health system. (AP)

Arkansas psychiatrist Brian Hyatt, MD, who once ran the state’s medical board and who has been accused in civil suits of imprisoning patients, was arrested for alleged Medicaid fraud. (NBC News)

Down syndrome families are pushing for inclusion in Alzheimer’s disease trials — the leading cause of death in this population. (Reuters)

In the midst of Israel’s conflict with Hamas, health experts warn that the mental health toll for people trapped in war zones can be as significant as the physical health toll. (ABC News)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

Source link

Share this Article
Leave a comment
adbanner